Reflection Asset Management’s Edwards Lifesciences EW Stock Holding History

Reflection Asset Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$47.6K	Buy	+558	New	+$45.8K	0.03%	250

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Reflection Asset Management's EW Position: Q4 2025 in Review

Reflection Asset Management opened a new position in Edwards Lifesciences (EW) in Q4 2025: 558 shares worth $47.6K. The stake represents 0.03% of the portfolio and ranks #250 among its holdings.

1,314 funds tracked by Wall St. Rank hold EW as of Q4 2025.

Reflection Asset Management held 558 shares of Edwards Lifesciences worth $47.6K as of Q4 2025.
Edwards Lifesciences was a new Reflection Asset Management position in Q4 2025.
Edwards Lifesciences made up 0.03% of Reflection Asset Management's portfolio in Q4 2025, its #250 holding.
1,314 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2025.

Based on Reflection Asset Management's 13F filing for Q4 2025, filed 2 Mar 2026.